Adapting a Brief Suicide Intervention for Pediatric Primary Care: Enhancing Uptake and Impact

Part of paid clinical trials in Centralia, Washington.

Sponsor
University of Washington
Study ID
NCT06499740
Status
Recruiting

Conditions

  • Suicide Prevention

Eligibility Criteria

Sex
ALL
Age
10 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Pilot Intervention — BEHAVIORAL
    This intervention is a suicide prevention intervention that will be adapted from evidence-based suicide prevention interventions including the SAFETY-Acute program. The specific intervention components will be determined from information gathered in this study but the investigators anticipate will include components such as identifying strengths, coping skills, safety planning, lethal means restriction, psychoeducation, motivation building, and care linkage.
  • Treatment as Usual — BEHAVIORAL
    Treatment as usual delivered in participating clinics.

Study Details

Suicide is a leading cause of death among adolescents in the United States and improving access to high quality just-in-time suicide interventions to reduce risk has important public health implications. Integrating such interventions into routinely accessed settings, such as pediatric primary care, holds promise; however, many clinicians in these settings fail to adequately screen or intervene in youth suicidal thoughts and behaviors, representing a key barrier to reducing suicide. The proposed study is a pre-post quasi-experimental pilot feasibility and preliminary efficacy trial of a suicide prevention intervention informed by evidence based interventions including the SAFETY-Acute suicide prevention intervention implemented in 3 pediatric primary care clinics.

Key Dates

Start date
May 4, 2026
Status verified
May 2026
Primary completion
Oct 31, 2027
Completion
Mar 31, 2028

Study Design

Enrollment
48 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Active Comparator: Treatment as usual
    Arm 1 entails months 1-2 of this study. Treatment as usual will be delivered by providers to adolescent patients in their clinics during the first two months of this study. Treatment as usual will be defined by each individual clinic based on their existing clinic protocols.
  • Experimental: Pilot Intervention
    Arm 2 entails months 3-4 of this study. Participating providers will deliver the adapted pilot intervention for the second half (months 3-4) of the pilot trial. The intervention will be based on the evidence-based suicide prevention interventions including the SAFETY-Acute protocol and will be adapted based on information from potential users prior to piloting. It is anticipated that both adolescent patients and their parents/caregivers will be involved in the intervention. Anticipated components of the intervention include psychoeducation, coping skills, safety planning, lethal means restriction, parenting skills, communication skills, identifying adolescent and family strengths, and linking to longer term care.

Primary Outcome Measure

Feasibility of Intervention Measure [ Time Frame: Participant and providers complete approximately 2 weeks after completing intervention ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Northwest PediatricsCentraliaWashington98531
Lily Lo, MD
(360) 736-6778
Richmond PediatricsMountlake TerraceWashington98043
Melissa Walsh, MD
(206) 546-2421
Olympia PediatricsOlympiaWashington98506
Janelle Tiegs
(360) 413-8470

Find similar trials in Centralia, WA

Related Studies